Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solesence (SLSN) Change in Accured Expenses (2016 - 2025)

Solesence (SLSN) has disclosed Change in Accured Expenses for 16 consecutive years, with -$849000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Accured Expenses fell 160.21% year-over-year to -$849000.0, compared with a TTM value of $2.1 million through Sep 2025, changed 0.43%, and an annual FY2024 reading of $4.0 million, up 2831.51% over the prior year.
  • Change in Accured Expenses was -$849000.0 for Q3 2025 at Solesence, down from $882000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $1.6 million in Q4 2024 and bottomed at -$849000.0 in Q3 2025.
  • Average Change in Accured Expenses over 5 years is $255368.4, with a median of $302000.0 recorded in 2021.
  • The sharpest move saw Change in Accured Expenses tumbled 1266.67% in 2021, then surged 734.36% in 2024.
  • Year by year, Change in Accured Expenses stood at -$310000.0 in 2021, then dropped by 4.52% to -$324000.0 in 2022, then rose by 20.06% to -$259000.0 in 2023, then soared by 734.36% to $1.6 million in 2024, then plummeted by 151.67% to -$849000.0 in 2025.
  • Business Quant data shows Change in Accured Expenses for SLSN at -$849000.0 in Q3 2025, $882000.0 in Q2 2025, and $419000.0 in Q1 2025.